Related Experiment Videos

Prevalence, symptoms and outcome of constipation in infants and toddlers

Vera Loening-Baucke1

  • 1Division of General Pediatrics, University of Iowa, Iowa City 52242-1083, USA. vera-loening-baucke@uiowa.edu

Insights

In children under two, constipation affects 2.9% in the first year and 10.1% in the second. Laxatives like milk of magnesia or polyethylene glycol are highly effective for treating pediatric constipation.

Area of Science:

  • Pediatrics
  • Gastroenterology

Background:

  • Constipation is a common pediatric issue.
  • Understanding its prevalence and effective treatments in young children is crucial.

Purpose of the Study:

  • Determine constipation prevalence in children under two years old.
  • Describe constipation symptoms and evaluate intervention effectiveness.
  • Assess the efficacy of dietary changes versus laxatives.

Main Methods:

  • Retrospective chart review of 4,157 children under two years of age.
  • Analysis of constipation prevalence, causes, and treatment outcomes.

Main Results:

  • Constipation prevalence was 2.9% in the first year and 10.1% in the second year of life.
  • Functional constipation accounted for 97% of cases; organic disease in 1.6%.
  • Dietary changes resolved constipation in 25% of cases, while laxatives (milk of magnesia, polyethylene glycol) resolved it in 92%.

Conclusions:

  • Laxatives are significantly more effective than dietary changes for pediatric constipation.
  • Milk of magnesia and polyethylene glycol are safe and efficient treatments for infants and toddlers.
Abstract

Related Concept Videos

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
Assessment of the Rectum and Anus01:25

Assessment of the Rectum and Anus

Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...